Tag: Pharmaceutical industry
Supreme Court Rules Against Purdue Pharma’s Liability Shield
The recent Supreme Court decision regarding Purdue Pharma's liability shield has sparked significant controversy and implications in the fight against the opioid epidemic. The court ruled against a provision in a multibillion-dollar settlement that...
Shortage of Insulin Pens in South Africa Due to Global Shift Towards Weight-Loss Drugs
South Africa is facing a critical shortage of human insulin pens, which are essential for people with diabetes. The pharmaceutical company Novo Nordisk, which has been supplying the country with these pens for the...
Protecting Patient Privacy: Pharma Giant’s Data Breach Discloses Sensitive Information
A data breach has affected U.S. pharmaceutical giant Cencora, exposing personal and sensitive medical information of individuals. The breach included patient names, addresses, dates of birth, health diagnoses, and medication details. The cyberattack began...
New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead
An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early symptoms of Alzheimer’s disease, such as mild cognitive impairment and...
Akira Endo, Scholar of Statins: Reducing Heart Disease – Dies at 90Statins Pioneer Akira...
Akira Endo, a renowned Japanese biochemist known for his groundbreaking research on fungi that led to the development of cholesterol-lowering drugs, passed away at the age of 90 on June 5. His work in...
Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...
An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured by Eli Lilly, was found to have modest benefits that...
FDA panel rejects MDMA-assisted therapies for PTSD veterans’ hopes dashed.New Title: FDA Panel...
The recent decision by a U.S. Food and Drug Administration (FDA) panel to reject MDMA-based treatments for post-traumatic stress disorder (PTSD) has left many veterans disappointed. The advisory committee voted 10-1 against the overall...
Is Semaglutide the ‘New Statin’? Not So Fast
Is Semaglutide the Breakthrough Treatment for Obesity and Cardiovascular Disease?
There has been much excitement surrounding the results of the SELECT cardiovascular outcomes trial (CVOT) presented at this year's European Congress on Obesity, with many...
Major drug companies caught up in Cencora data loss
Pharma Giants Hit by Major Data BreachIn a recent data breach incident, more than a dozen major pharmaceutical companies have been affected by the breach of US drug wholesaler Cencora. This $250-billion firm, formerly...